Summary: Dana Investment Advisors boosted its Regeneron stake 58% in Q4 to 8,395 shares worth $6.48M after solid results; analysts maintain a Moderate Buy with a $826.59 target, despite the stock trading below its 52-week high.Abstract: Dana Investment Advisors increased its Regeneron stake by 58% in the fourth quarter, totaling 8,395 shares valued at about $6.48 million, following strong quarterly performance. Analysts maintain a Moderate Buy rating with an average target of $826.59, even as the stock trades below its 52-week high.

NodeGuardian

2026-05-18 04:59:06

Abstract generation in progress

Dana Investment Advisors Inc. significantly increased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 58% in the fourth quarter, now holding 8,395 shares valued at $6.48 million. This increase follows strong quarterly results where Regeneron exceeded revenue and EPS forecasts. Analyst sentiment remains largely positive, maintaining a "Moderate Buy" consensus and an average target price of $826.59, despite the stock trading below its 52-week high.

REGN-0.64%

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
TradfiTradingChallenge
366.24K Popularity
#
USIranDraftDeal
279.55K Popularity
#
DailyPolymarketHotspot
1.06M Popularity
#
HYPEMarketCapSurpassesDOGE
12.63M Popularity
#
PlatinumCardCreatorExclusive
151.51K Popularity

Pinned

Sitemap

Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by Dana Investment Advisors Inc.

Trending Topics

TradfiTradingChallenge

USIranDraftDeal

DailyPolymarketHotspot

HYPEMarketCapSurpassesDOGE

PlatinumCardCreatorExclusive

Pinned